Exercise-induced bronchoconstriction update: Therapeutic management

Allergy and Asthma Proceedings

Volumn 33, Issue 1, 2012, Pages 7-12

  Spector, Sheldon ^a,b   Tan, Ricardo ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b California Allergy and Asthma Medical Group Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARFORMOTEROL; ASCORBIC ACID; ATROPINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FISH OIL; FORMOTEROL; IPRATROPIUM BROMIDE; MONTELUKAST; NEDOCROMIL; PLACEBO; SALMETEROL; VITAMIN D; ZAFIRLUKAST; ZILEUTON;

ATHLETE; BRONCHOSPASM; CONFERENCE PAPER; DIETARY INTAKE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERANCE; EXERCISE; EXERCISE INDUCED BRONCHOCONSTRICTION; HUMAN; SINGLE DRUG DOSE; SODIUM RESTRICTION;

ADRENAL CORTEX HORMONES; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ASTHMA, EXERCISE-INDUCED; ATHLETES; DIET; DISEASE MANAGEMENT; HUMANS; MAST CELLS;

EID: 84857497029     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2012.33.3497     Document Type: Conference Paper

References (55)

1. Weiler JM, Anderson SD, Randolph C, et al. Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: A practice parameter. Ann Allergy Asthma Immunol 105(suppl):S1-S47, 2010.
2. National Heart Lung and Blood Institute. Guidelines for the diagnosis and management of asthma. National Asthma Education and Prevention Program Expert Panel Report 3, National Heart Lung and Blood Institute, Rockville, MD, 2007.
3. Svenonius E, Kautto R, and Arborelius M Jr. Improvement after training of children with exercise-induced asthma. Acta Paediatr Scand 72:23-30, 1983. (Pubitemid 13191959)
4. Henriksen JM, and Nielsen TT. Effect of physical training on exercise-induced bronchoconstriction. Acta Paediatr Scand 72: 31-36, 1983. (Pubitemid 13191960)
5. Haas F, Pasierski S, Levine N, et al. Effect of aerobic training on forced expiratory airflow in exercising asthmatic humans. J Appl Physiol 63:1230-1235, 1987. (Pubitemid 17156288)
6. Satta A. Exercise training in asthma. J Sports Med Phys Fitness 40:277-2783, 2000.
7. Mickleborough TD, Lindley MR, and Turner LA. Comparative effects of a high-intensity interval warm-up and salbutamol on the bronchoconstrictor response to exercise in asthmatic athletes. Int J Sports Med 28:456-462, 2007. (Pubitemid 46953747)
8. Provost-Craig MA, Arbour KS, Sestili DC, et al. The incidence of exercise-induced bronchospasm in competitive figure skaters. J Asthma 33:67-71, 1996. (Pubitemid 26058828)
9. Mannix ET, Manfredi F, and Farber MO. A comparison of two challenge tests for identifying exercise-induced bronchospasm in figure skaters. Chest 115:649-653, 1999. (Pubitemid 29129939)
10. Schachter EN, Lach E, and Lee M. The protective effect of a cold weather mask on exercised-induced asthma. Ann Allergy 46: 12-16, 1981. (Pubitemid 11176844)
11. Gotshall RW, Mickleborough TD, and Cordain L. Dietary salt restriction improves pulmonary function in exercise-induced asthma. Med Sci Sports Exerc 32:1815-1819, 2000.
12. Mickleborough TD, and Fogarty A. Dietary sodium intake and asthma: An epidemiological and clinical review. Int J Clin Pract 60:1616-1624, 2006. (Pubitemid 44742162)
13. Mickleborough TD, Lindley MR, and Montgomery GS. Effect of fish oil-derived omega-3 polyunsaturated fatty acid supplementation on exercise-induced bronchoconstriction and immune function in athletes. Phys Sportsmed 36:11-17, 2008.
14. Tecklenburg SL, Mickleborough TD, Fly AD, et al. Ascorbic acid supplementation attenuates exercise-induced bronchoconstriction in patients with asthma. Respir Med 101:1770-1778, 2007. (Pubitemid 46930706)
15. McFadden ER Jr, and Gilbert IA. Exercise-induced asthma. N Engl J Med 330:1362-1367, 1994. (Pubitemid 24136061)
16. Tan RA, and Spector SL. Exercise-induced asthma: diagnosis and management. Ann Allergy Asthma Immunol 89:226-235, 2002.
17. Anderson SD, Caillaud C, and Brannan JD. Beta2-agonists and exercise-induced asthma. Clin Rev Allergy Immunol 31:163-180, 2006.
18. Anderson SD, Seale JP, Rozea P, et al. Inhaled and oral salbutamol in exercise-induced asthma. Am Rev Respir Dis 114:493-500, 1976.
19. Pearlman DS, Rees W, Schaefer K, et al. An evaluation of levalbuterol HFA in the prevention of exercise-induced bronchospasm. J Asthma 44:729-733, 2007. (Pubitemid 350125584)
20. Ferrari M, Balestreri F, Baratieri S, et al. Evidence of the rapid protective effect of formoterol dry-powder inhalation against exercise-induced bronchospasm in athletes with asthma. Respiration 67:510-513, 2000.
21. Kemp JP, Dockhorn RJ, Busse WW, et al. Prolonged effect of inhaled salmeterol against exercise-induced bronchospasm. Am J Respir Crit Care Med 150:1612-1615, 1994. (Pubitemid 24361735)
22. Ferrari M, Segattini C, Zanon R, et al. Comparison of the protective effect of formoterol and of salmeterol against exercise-induced bronchospasm when given immediately before a cycloergometric test. Respiration 69:509-512, 2002. (Pubitemid 35404293)
23. Nelson JA, Strauss L, Skowronski M, et al. Effect of long-term salmeterol treatment on exercise-induced asthma. N Engl J Med 339:141-146, 1998. (Pubitemid 28328477)
24. Haney S, and Hancox RJ. Recovery from bronchoconstriction and bronchodilator tolerance. Clin Rev Allergy Immunol 31: 181-196, 2006. (Pubitemid 44804947)
25. Haney S, and Hancox RJ. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial. Respir Res 6:107, 2005.
26. Drotar DE, Davis EE, and Cockcroft DW. Tolerance to the bronchoprotective effect of salmeterol 12 hours after starting twice daily treatment. Ann Allergy Asthma Immunol 80:31-34, 1998. (Pubitemid 28086752)
27. Johnson M. Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation. J Allergy Clin Immunol 117:18-24, 2006. (Pubitemid 43017132)
28. Scola AM, Chong LK, Suvarna SK, et al. Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol. Br J Pharmacol 141:163-171, 2004. (Pubitemid 38241174)
29. Hancox RJ, Subbarao P, Kamada D, et al. Beta2-agonist tolerance and exercise-induced bronchospasm. Am J Respir Crit Care Med 165:1068-1070, 2002.
30. Weinberger M, and Abu-Hasan M. Life-threatening asthma during treatment with salmeterol. N Engl J Med 355:852-853, 2006.
31. Inman MD, and O'Byrne PM. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction. Am J Respir Crit Care Med 153:65-69, 1996. (Pubitemid 26026828)
32. Davis BE, Reid JK, and Cockcroft DW. Formoterol thrice weekly does not result in the development of tolerance to bronchoprotection. Can Respir J 10:23-26, 2003. (Pubitemid 36416727)
33. Simons FE, Gerstner TV, and Cheang MS. Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment. Pediatrics 99:655-659, 1997. (Pubitemid 27193764)
34. Weiler JM, Nathan RA, Rupp NT, et al. Effect of fluticasone/salmeterol administered via a single device on exercise-induced bronchospasm in patients with persistent asthma. Ann Allergy Asthma Immunol 94:65-72, 2005. (Pubitemid 40129638)
35. Philip G, Pearlman DS, Villaran C, et al. Single-dose montelukast or salmeterol as protection against exercise-induced bronchoconstriction. Chest 132:875-883, 2007.
36. Philip G, Villaran C, Pearlman DS, et al. Protection against exercise-induced bronchoconstriction two hours after a single oral dose of montelukast. J Asthma 44:213-217, 2007. (Pubitemid 46598156)
37. Coreno A, Skowronski M, Kotaru C, and McFadden ER Jr. Comparative effects of long-acting beta2-agonists, leukotriene receptor antagonists, and a 5-lipoxygenase inhibitor on exercise-induced asthma. J Allergy Clin Immunol 106:500-506, 2000. (Pubitemid 32040916)
38. Leff JA, Busse WW, Pearlman D, et al. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med 339:147-152, 1998. (Pubitemid 28328478)
39. Raissy HH, Harkins M, Kelly F, and Kelly HW. Pretreatment with albuterol versus montelukast for exercise-induced bronchospasm in children. Pharmacotherapy 28:287-294, 2008. (Pubitemid 351328900)
40. Villaran C, O'Neill SJ, Helbling A, et al. Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group. J Allergy Clin Immunol 104:547-553, 1999. (Pubitemid 29451642)
41. Fogel RB, Rosario N, Aristizabal G, et al. Effect of montelukast or salmeterol added to inhaled fluticasone on exercise-induced bronchoconstriction in children. Ann Allergy Asthma Immunol 104:511-517, 2010.
42. de Benedictis FM, Vaccher S, and de Benedictis D. Montelukast sodium for exercise-induced asthma. Drugs Today (Barc) 44: 845-855, 2008.
43. de Benedictis FM, del GiudiceMM,Forenza N, et al. Lack of tolerance to the protective effect of montelukast in exercise-induced bronchoconstriction in children. Eur Respir J 28:291-295, 2006. (Pubitemid 44914226)
44. Meltzer SS, Hasday JD, Cohn J, and Bleecker ER. Inhibition of exercise-induced bronchospasm by zileuton: A 5-lipoxygenase inhibitor. Am J Respir Crit Care Med 153:931-935, 1996. (Pubitemid 26081641)
45. Kippelen P, Larsson J, Anderson SD, et al. Effect of sodium cromoglycate on mast cell mediators during hyperpnea in athletes. Med Sci Sports Exerc 42:1853-1860, 2010.
46. Woolley M, Anderson SD, and Quigley BM. Duration of protective effect of terbutaline sulfate and cromolyn sodium alone and in combination on exercise-induced asthma. Chest 97:39-45, 1990. (Pubitemid 20023489)
47. Kelly KD, Spooner CH, and Rowe BH. Nedocromil sodium versus sodium cromoglycate in treatment of exercise-induced bronchoconstriction: A systematic review. Eur Respir J 17:39-45, 2001. (Pubitemid 32600554)
48. Tullett WM, Tan KM, Wall RT, and Patel KR. Dose-response effect of sodium cromoglycate pressurised aerosol in exercise induced asthma. Thorax 40:41-44, 1985. (Pubitemid 15110830)
49. Patel KR, and Wall RT. Dose-duration effect of sodium cromoglycate aerosol in exercise-induced asthma. Eur J Respir Dis 69:256-260, 1986. (Pubitemid 17171699)
50. Spooner CH, Spooner GR, and Rowe BH. Mast-cell stabilising agents to prevent exercise-induced bronchoconstriction. Cochrane Database Syst Rev 4:CD002307, 2003.
51. de Benedictis FM, Tuteri G, Pazzelli P, et al. Combination drug therapy for the prevention of exercise-induced bronchoconstriction in children. Ann Allergy Asthma Immunol 80:352-356, 1998. (Pubitemid 28183595)
52. Poppius H, Sovijarvi AR, and Tammilehto L. Lack of protective effect of high-dose ipratropium on bronchoconstriction following exercise with cold air breathing in patients with mild asthma. Eur J Respir Dis 68:319-325, 1986. (Pubitemid 16088440)
53. Magnussen H, Nowak D, and Wiebicke W. Effect of inhaled ipratropium bromide on the airway response to methacholine, histamine, and exercise in patients with mild bronchial asthma. Respiration 59:42-47, 1992.
54. Sue-Chu M, Karjalainen EM, Laitinen A, et al. Placebo-controlled study of inhaled budesonide on indices of airway inflammation in bronchoalveolar lavage fluid and bronchial biopsies in cross-country skiers. Respiration 67:417-425, 2000. (Pubitemid 30666005)
55. Spector SL, and Farr RS. The heterogeneity of asthmatic patients-An individualized approach to diagnosis and treatment. J Allergy Clin Immunol 57:499-511, 1976.